Published in Cell Mol Life Sci on December 20, 2012
The ubiquitin system. Annu Rev Biochem (1998) 43.36
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
Signaling to NF-kappaB. Genes Dev (2004) 19.78
Function and activation of NF-kappa B in the immune system. Annu Rev Immunol (1994) 17.04
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
Principles of CDK regulation. Nature (1995) 13.09
Cell cycle control and cancer. Science (1994) 10.90
Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol (2003) 10.29
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol (1999) 9.92
Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 9.73
NF-kappaB: a key role in inflammatory diseases. J Clin Invest (2001) 9.66
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell (1994) 9.48
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res (1994) 9.00
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell (1996) 8.89
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (1994) 8.22
TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science (1995) 6.41
Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science (1994) 6.11
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer (2008) 6.10
Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J (2000) 5.61
Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol (2004) 5.43
p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol (1999) 5.40
Smads: transcriptional activators of TGF-beta responses. Cell (1998) 5.33
Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (1994) 5.12
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med (1997) 5.10
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol (1999) 4.98
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev (1995) 4.87
Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest (1992) 4.49
TGF-beta signaling in renal disease. J Am Soc Nephrol (2002) 4.21
Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev (1995) 4.19
Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A (2000) 4.08
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int (2009) 4.02
The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol (2001) 3.87
TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J (2002) 3.80
Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science (1996) 3.74
Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem (2003) 3.68
Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol (1997) 3.67
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature (1995) 3.56
Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol (2002) 3.44
Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell (2000) 3.42
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature (1994) 3.21
Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol (2004) 3.14
IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell (2001) 3.10
Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int (1999) 3.09
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med (2008) 2.99
Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol (1996) 2.97
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell (2001) 2.61
Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev (1998) 2.39
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35
Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) (2005) 2.23
Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest (1993) 2.13
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res (1997) 2.05
A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol (2002) 1.77
Regulating protein degradation by ubiquitination. Immunol Today (1997) 1.71
Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int (1994) 1.70
Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury. Kidney Int (2006) 1.70
The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy. J Am Soc Nephrol (2003) 1.63
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol (2003) 1.60
Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol (2006) 1.58
Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol (2002) 1.52
Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int (2000) 1.49
A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol (1996) 1.43
IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression. EMBO J (2006) 1.43
The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol (1996) 1.42
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol (1998) 1.41
Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A (2004) 1.41
An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease. Kidney Int (2010) 1.39
Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol (1999) 1.34
Retracted The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol Cell (2010) 1.34
TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol (2004) 1.33
Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. Cancer Res (2007) 1.33
The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med (1998) 1.32
Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem (2003) 1.32
TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol (1998) 1.23
Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int (1988) 1.22
Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest (1987) 1.22
Cell cycle regulation and differentiation in the human podocyte lineage. Am J Pathol (1998) 1.17
TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Regul Integr Comp Physiol (2006) 1.16
Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling. Kidney Int (2004) 1.15
Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int (1997) 1.11
Podocyte expression of the CDK-inhibitor p57 during development and disease. Kidney Int (2001) 1.07
Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition. Mol Cell Biol (2007) 1.07
Cancer prognostics: past, present and p27. Nat Med (1997) 1.06
The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy. J Am Soc Nephrol (1998) 1.05
Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int (1996) 1.05
Involvement of renal progenitor tubular cells in epithelial-to-mesenchymal transition in fibrotic rat kidneys. J Am Soc Nephrol (2005) 1.01
Diabetic nephropathy. J Am Soc Nephrol (1997) 1.00
Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol (1999) 1.00
Blocking core fucosylation of TGF-β1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells. Am J Physiol Renal Physiol (2011) 1.00
Spatial and temporal expression of p57(KIP2) during murine lens development. Mech Dev (1999) 0.99
Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: possible role of nuclear factor kappaB. Int J Mol Med (2003) 0.98
Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis (1994) 0.97
TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res (2006) 0.97
The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int (1999) 0.95
Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling. Oncogene (2004) 0.94
Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int (1997) 0.94
Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages. J Biol Chem (2001) 0.93
Transcriptional induction of Smurf2 ubiquitin ligase by TGF-beta. FEBS Lett (2005) 0.91
Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis. Am J Pathol (2003) 0.90
Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia. Kidney Int (1998) 0.90
Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell (2004) 3.27
Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol (2008) 2.15
Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J (2003) 2.13
Novel sandwich ELISA for human angiotensinogen. Am J Physiol Renal Physiol (2007) 1.99
Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension (2008) 1.99
Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. Am J Physiol Renal Physiol (2007) 1.87
Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol (2007) 1.73
Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens (2010) 1.60
Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J (2004) 1.57
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J (2007) 1.52
Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation. EMBO J (2004) 1.47
Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A (2004) 1.41
Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol (2008) 1.37
Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci (2009) 1.34
Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol (2008) 1.34
Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am J Physiol Renal Physiol (2008) 1.34
Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. Cancer Res (2007) 1.33
Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant (2010) 1.32
Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis. Cancer Res (2006) 1.31
Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol (2009) 1.30
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant (2010) 1.29
Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens (2010) 1.22
TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res (2008) 1.18
Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy. Biomark Insights (2009) 1.17
Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling. Kidney Int (2004) 1.15
High expression of Cks1 in human non-small cell lung carcinomas. Biochem Biophys Res Commun (2003) 1.11
Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro. J Biochem (2005) 1.11
Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. Cancer Res (2003) 1.09
Critical and functional regulation of CHOP (C/EBP homologous protein) through the N-terminal portion. J Biol Chem (2007) 1.08
Cell cycle-dependent regulation of the human aurora B promoter. Biochem Biophys Res Commun (2004) 1.08
Cellular FLIP inhibits beta-catenin ubiquitylation and enhances Wnt signaling. Mol Cell Biol (2004) 1.04
Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade. J Hypertens (2010) 1.04
Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Sci Transl Med (2012) 1.04
IL-6 augments angiotensinogen in primary cultured renal proximal tubular cells. Mol Cell Endocrinol (2009) 1.03
Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats. Am J Physiol Renal Physiol (2008) 1.03
Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. Cancer Res (2006) 0.99
Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. J Pharmacol Exp Ther (2009) 0.98
Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte. J Hypertens (2010) 0.93
Generation of a constitutively active mutant of human GPR48/LGR4, a G-protein-coupled receptor. Hokkaido Igaku Zasshi (2006) 0.93
Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats. J Hypertens (2011) 0.92
Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma. Int J Cancer (2010) 0.92
Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension (2011) 0.91
High expression of Pirh2, an E3 ligase for p27, is associated with low expression of p27 and poor prognosis in head and neck cancers. Cancer Sci (2009) 0.91
Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway. Development (2011) 0.91
Transcriptional induction of Smurf2 ubiquitin ligase by TGF-beta. FEBS Lett (2005) 0.91
Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner. Biochem Biophys Res Commun (2005) 0.90
Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis. Am J Pathol (2003) 0.90
Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett (2006) 0.89
Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase. J Biol Chem (2009) 0.89
Enhanced intrarenal receptor-mediated prorenin activation in chronic progressive anti-thymocyte serum nephritis rats on high salt intake. Am J Physiol Renal Physiol (2012) 0.89
Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Biochem Biophys Res Commun (2003) 0.89
YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers. Genes Cells (2014) 0.88
Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage. Clin Exp Nephrol (2014) 0.87
Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts. Int J Cancer (2014) 0.86
The FWD1/beta-TrCP-mediated degradation pathway establishes a 'turning off switch' of a Cdc42 guanine nucleotide exchange factor, FGD1. Genes Cells (2005) 0.86
GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms. Cell Div (2010) 0.85
Immunohistochemical and genetic features of gastric and metastatic liver gastrointestinal stromal tumors: sequential analyses. Cancer Sci (2006) 0.84
Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice. Am J Pathol (2007) 0.84
Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signaling. J Interferon Cytokine Res (2004) 0.83
Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors. Cancer Sci (2007) 0.83
Effects of MdmX on Mdm2-mediated downregulation of pRB. FEBS Lett (2006) 0.83
Immunohistochemical study on caveolin-1alpha in regenerating process of tubular cells in gentamicin-induced acute tubular injury in rats. Virchows Arch (2007) 0.82
Pirh2 interacts with and ubiquitylates signal recognition particle receptor beta subunit. Biomed Res (2008) 0.82
ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells. Carcinogenesis (2007) 0.81
Dual mode of regulation of cell division cycle 25 A protein by TRB3. Biol Pharm Bull (2010) 0.81
Chk1 phosphorylates the tumour suppressor Mig-6, regulating the activation of EGF signalling. EMBO J (2012) 0.81
Ubiquitin-dependent degradation of adenovirus E1A protein is inhibited by BS69. Biochem Biophys Res Commun (2005) 0.80
The amelioration of renal damage in Skp2-deficient mice canceled by p27 Kip1 deficiency in Skp2-/- p27-/- mice. PLoS One (2012) 0.80
Decrease in tumor necrosis factor-alpha receptor-associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats. Am J Pathol (2009) 0.80
Up-regulation of Cks1 and Skp2 with TNFα/NF-κB signaling in chronic progressive nephropathy. Genes Cells (2011) 0.80
Cks1 is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner. Genes Cells (2003) 0.80
Rapid improvement of acute pulmonary edema with angiotensin converting enzyme inhibitor under hemodialysis in a patient with renovascular disease. Ther Apher Dial (2004) 0.79
Contribution of extracellular signal-regulated kinases to the IL-1-induced growth inhibition of human melanoma cells A375. Int Immunopharmacol (2007) 0.78
Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development. Mol Cell Biol (2014) 0.78
YB1 binds to and represses the p16 tumor suppressor gene. Genes Cells (2013) 0.78
The SCF ubiquitin ligases involved in hematopoietic lineage. Curr Drug Targets (2012) 0.78
Transient leukopenia and anaphylatoxin production during granulocyte apheresis as treatment for ulcerative colitis. J Clin Apher (2002) 0.78
Hepatocyte Growth Factor stimulated cell scattering requires ERK and Cdc42-dependent tight junction disassembly. Biochem Biophys Res Commun (2010) 0.78
Analyses in transfected cells and in vitro of a putative peroxisomal targeting signal of rat liver serine:pyruvate aminotransferase. Histochem Cell Biol (2002) 0.78
The role of Sp1 and AP-2 in basal and protein kinase A--induced expression of mitochondrial serine:pyruvate aminotransferase in hepatocytes. J Biol Chem (2002) 0.77
Cdk4/cyclin D1 kinase, a universal and critical regulator of apoptosis. Anticancer Res (2003) 0.77
Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia. Neuromolecular Med (2006) 0.77
Regulation of DNA replication licensing. Curr Drug Targets (2012) 0.76
RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer. Curr Cancer Drug Targets (2016) 0.76
Kaposi's sarcoma-associated herpesvirus-encoded LANA positively affects on ubiquitylation of p53. Biochem Biophys Res Commun (2010) 0.76
Severity of Gastric Mucosal Atrophy Is the Major Determinant of Plasma Ghrelin Level in Hemodialysis Patients. Am J Nephrol (2016) 0.76
Cys-881 is essential for the trafficking and secretion of truncated mutant ceruloplasmin in aceruloplasminemia. J Hepatol (2007) 0.76
Interaction between RB protein and NuMA is required for proper alignment of spindle microtubules. Genes Cells (2013) 0.76
Role of the second-largest subunit of DNA polymerase alpha in the interaction between the catalytic subunit and hyperphosphorylated retinoblastoma protein in late S phase. Biochim Biophys Acta (2006) 0.76
Calcitriol-induced hypercalcemia in a patient with granulomatous mycosis fungoides and end-stage renal disease. World J Nephrol (2013) 0.75
Tubulointerstitial nephritis and primary biliary cirrhosis with a T cell-dominant profile of infiltrating cells and granulomas in both organs. Intern Med (2013) 0.75